AOD-9604
ResearchAOD-9604 (HGH Fragment 176-191)
- Category
- Weight Loss & Metabolism
- Aliases
- HGH Fragment 176-191, Anti-Obesity Drug 9604
- Administration
- Subcutaneous injection
Documented side effects
Tier 1 · Peer-reviewed / regulatoryGenerally well-tolerated in trials
Clinical trial participants did not report significant adverse effects.
Efficacy for weight loss not established vs. placebo
Clinical trial data did not show a meaningfully greater weight-loss effect compared to an inactive placebo.